Dr. Kristi Wrightson, ND, is assessing the effectiveness of an investigational light-based medical device in reducing the severity and duration of influenza symptoms
Since the beginning of this winter’s flu season in September, there have been more than 90,000 confirmed cases of influenza in the United States. In California, the influenza virus has recently started to spread. Dr. Kristi Wrightson, ND is looking toward the light to fight this malicious winter bug.
Today, Wrightson launched an influenza study to assess the ability of an investigational light-based medical device by UVLrx Therapeutics to reduce the severity and duration of influenza symptoms, both systemic and upper respiratory.
The treatment device uses specific wavelengths of light to target the influenza virus while supporting the body's immune system to help combat or fight the viral infection. The study aims at assessing the effectiveness and safety of this application.
These symptoms can last between 7 to 14 days and can greatly alter a person's quality of life and ability to work.
Study participants will undergo four sixty-minute treatments in one week in a medical clinic at no cost to the patient. Additionally, participants will return to the clinic for two more evaluations to assess symptom resolution.
To participate in the study, please call (805) 770-2607 or visit the Nest at 523 Chapala St. #2, Santa Barbara, CA 93101.